90% of Your Serotonin Is Made in Your Gut. Here’s What That Means for Your Mood

Most people think of serotonin as a brain chemical, but roughly 90% of the body's supply is produced in the gut, shaped by the microbial communities living there. A review by Z Maq, published in the journal Immunity and Inflammation, maps the four main pathways through which gut bacteria communicate with the brain, and explores what happens to mood and behavior when those pathways are disrupted. The picture that emerges is still preliminary, but it reframes how scientists think about anxiety, depression, and even neurological disease.

How gut bacteria produce serotonin, GABA, and the signals that shape mood

The gut is not a passive digestive tube. It houses the enteric nervous system, a dense web of neurons sometimes called the "second brain," and it sends signals upward through the vagus nerve, the immune system, the neuroendocrine system, and metabolic byproducts called short-chain fatty acids (SCFAs). According to the review, gut microbiome modulates brain function by influencing neurodevelopment, neurotransmission, and behavior through each of these routes simultaneously.

The serotonin figure is striking on its own: approximately 90% of the body's serotonin is synthesized in the gut, where it helps regulate motility, but it also feeds into mood and emotional health through gut-brain signaling. Separately, certain gut bacteria produce GABA, the neurotransmitter most associated with reducing anxiety and fear. When microbial communities are disrupted, a state called dysbiosis, both of these neurotransmitter systems can fall out of balance, potentially contributing to the mood disturbances researchers observe in people with gut disorders.

SCFAs, produced when gut bacteria ferment dietary fiber, are another critical piece. These molecules influence the integrity of the gut's mucosal barrier, which is built partly from a protein called Muc2. When the barrier holds, bacterial metabolites stay in the gut. When it doesn't, they can enter circulation and, the review argues, eventually influence neurological function.

Gut dysbiosis, inflammation, and the risk of anxiety and depression

A diet high in processed food and low in fiber shifts the composition of gut bacteria in ways that appear to promote chronic inflammation. The review describes how this can feed into mood disorders: inflammation disrupts neurotransmitter production, generates oxidative stress, and may trigger neuroinflammation. The bidirectional gut-brain axis means the relationship runs both ways; a landmark experiment by Sudo and colleagues found that germ-free mice, raised without any gut bacteria, showed an impaired stress response, suggesting the microbiome shapes the HPA axis from early in life.

The HPA axis is the body's central stress-response circuit: stress activates the release of corticotropin-releasing hormone (CRH), which triggers adrenocorticotropic hormone (ACTH), which in turn stimulates cortisol production. The review notes that sustained HPA activation can physically compromise gut barrier integrity, creating a feedback loop where stress damages the gut, and a damaged gut amplifies the stress response.

Beyond mood disorders, the review flags connections to broader neurological disease. Dysbiosis and compromised gut barrier function can facilitate the movement of bacterial metabolites into systemic circulation, potentially contributing to conditions including stress-related illness and ischemic stroke. Emerging research now links gut-brain axis disruption to neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as autism spectrum disorder, though causal pathways in humans remain poorly understood.

What the review's methodology can and cannot tell us

The paper is a narrative review, not an original clinical trial. It synthesizes existing literature on gut barrier structure and the four gut-brain communication pathways, with particular focus on the gut barrier's role in acute neurological events like ischemic stroke. That framing is useful for organizing a complex field, but it means the conclusions depend entirely on the quality and consistency of the studies it draws from.

A persistent challenge in this field is that much foundational work has been done in animal models, which may not translate cleanly to humans. As one analysis of the existing gut-brain literature notes, limitations of animal models in gut-brain research are significant, and the long-term effects of dietary and microbial interventions on gut stability in humans are still not well characterized. Correlations between dysbiosis and mood disorders are well documented; whether fixing the gut reliably fixes the mood is a harder question.

Probiotics, FMT, and the open questions around gut-targeted therapies

The review describes three therapeutic approaches gaining traction: probiotics (live beneficial bacteria), prebiotics (dietary compounds that feed those bacteria), and fecal microbiota transplantation (FMT), which involves transferring a healthy donor's gut community to a recipient. Each targets the gut-brain axis at a different point, and each carries its own evidentiary uncertainties.

On the probiotic side specifically, a meta-analysis published in the American Journal of Clinical Nutrition found that up to eight weeks of probiotics reduce depression and anxiety symptoms in clinically diagnosed patients, with single-strain formulations showing the strongest effect. But the same body of research acknowledges that optimal dosing, strain selection, and treatment timing remain unresolved. A separate comprehensive review of clinical trials from 2014 to 2023 found inconsistent probiotic effects on mood, cautioning that the precise mechanisms are still being worked out and that results vary considerably across populations.

For most people, the most accessible intervention remains diet. A diet rich in fiber, healthy fats, and antioxidants supports microbial diversity and a healthy inflammatory response. That is not a novel claim, but the gut-brain axis research gives it a more specific mechanistic basis: fiber feeds the bacteria that produce SCFAs, SCFAs help maintain the gut barrier, the gut barrier limits microbial translocation, and all of that connects, through the vagus nerve and the neuroendocrine system, to how you feel on a given day. The biology is genuinely complex, and the therapeutic applications are still early. But the link between what you eat and how your brain functions is looking increasingly concrete.